ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Winter Conference & Expo
November 15–18, 2026
Phoenix, AZ|Arizona Grand Resort & Spa
Latest Magazine Issues
Aug 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
September 2026
Fusion Science and Technology
August 2026
Latest News
LLNL, Ampera partner to develop thorium-based TRISO fuel
Lawrence Livermore National Laboratory has formed a strategic partnership with Ampera to develop the company’s nuclear fuel concept through a project named THUNDER, for Thorium Unimodal Droplet Ejection for Reactors.
The focus of THUNDER is fabricating TRISO made with kernels of thorium rather than the usual uranium. LLNL and Ampera will evaluate and optimize liquid metal–jetting technology to produce highly uniform, spherical kernels of thorium-232 for later processing into TRISO fuel.
Hungyuan B. Liu, Francis J. Patti
Nuclear Technology | Volume 116 | Number 3 | December 1996 | Pages 373-377
Technical Note | Heat Transfer and Fluid Flow | doi.org/10.13182/NT96-A35292
Articles are hosted by Taylor and Francis Online.
Recent changes are updated for the proposed modification to use a fission plate converter and a matching filter/moderator assembly in a newly designed beam shutter to enhance the epithermal neutron beam for patient irradiations during boron neutron capture therapy (BNCT) at the Brookhaven Medical Research Reactor, Brookhaven National Laboratory. Engineering design of the new beam shutter system has been completed, and design review is under way. With this upgrade, the epithermal neutron flux could be increased up to seven times higher than the present beam, and the fast-neutron dose per epithermal neutron fluence could be reduced to near half. Such an enhanced epithermal neutron beam would increase the effectiveness of clinical BNCT by allowing increased doses to the tumor with similar or lesser doses to normal tissues.